Eligible healthcare professionals' organisations

SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD) for Sponsors, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 11 October 2024, 10:00 (CEST) to 11 October 2024, 12:00 (CEST)

Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 6, Status: Authorised

Clinical Trials Information System: training and support

Human medicines European public assessment report (EPAR): Arexvy, Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Tyverb, lapatinib, Date of authorisation: 10/06/2008, Revision: 36, Status: Authorised

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

LifeGlobal Media - Procedural steps and scientific information after initial consultation

Seizing opportunities in a changing medicines landscape